# 12-Month Efficacy of Exercise and Cytisinicline for Tobacco Abstinence

> **NCT06579846** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Maimónides Biomedical Research Institute of Córdoba** · enrollment: 150 (estimated)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** Cytisinicline and exercise
- **DRUG:** Cytisinicline

## Key facts

- **NCT ID:** NCT06579846
- **Lead sponsor:** Maimónides Biomedical Research Institute of Córdoba
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2024-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06579846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06579846, "12-Month Efficacy of Exercise and Cytisinicline for Tobacco Abstinence". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06579846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*